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Abstract
Disorders of mitochondrial fat metabolism lead to sudden death in infants and children. Although survival is possible, the
underlying molecular mechanisms which enable this outcome have not yet been clearly identified. Here we describe a
conserved genetic network linking disorders of mitochondrial fat metabolism in mice to mechanisms of fat storage and
survival in Caenorhabditis elegans (C. elegans). We have previously documented a mouse model of mitochondrial very-long
chain acyl-CoA dehydrogenase (VLCAD) deficiency.[1] We originally reported that the mice survived birth, but, upon
exposure to cold and fasting stresses, these mice developed cardiac dysfunction, which greatly reduced survival. We used
cDNA microarrays[2,3,4] to outline the induction of several markers of lipid metabolism in the heart at birth in surviving
mice. We hypothesized that the induction of fat metabolism genes in the heart at birth is part of a regulatory feedback
circuit that plays a critical role in survival.[1] The present study uses a dual approach employing both C57BL/6 mice and the
nematode, C. elegans, to focus on TMEM135, a conserved protein which we have found to be upregulated 4.3 (60.14)-fold
in VLCAD-deficient mice at birth. Our studies have demonstrated that TMEM135 is highly expressed in mitochondria and in
fat-loaded tissues in the mouse. Further, when fasting and cold stresses were introduced to mice, we observed 3.25 (60.03)-
and 8.2 (60.31)- fold increases in TMEM135 expression in the heart, respectively. Additionally, we found that deletion of the
tmem135 orthologue in C. elegans caused a 41.8% (62.8%) reduction in fat stores, a reduction in mitochondrial action
potential and decreased longevity of the worm. In stark contrast, C. elegans transgenic animals overexpressing TMEM-135
exhibited increased longevity upon exposure to cold stress. Based on these results, we propose that TMEM135 integrates
biological processes involving fat metabolism and energy expenditure in both the worm (invertebrates) and in mammalian
organisms. The data obtained from our experiments suggest that TMEM135 is part of a regulatory circuit that plays a critical
role in the survival of VLCAD-deficient mice and perhaps in other mitochondrial genetic defects of fat metabolism as well.
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Introduction
The verylong-chainacyl-CoAdehydrogenase(VLCAD)enzyme
catalyzes the first step in the mitochondrial fatty acid b-oxidation
spiral. Fatty acids are the preferred substrates for ATP generation
in the heart, skeletal muscles and high energy requiring tissues. It is
well documented that mutation in the VLCAD gene leads to
cardiomyopathy, skeletal myopathy, encephalopathy and sudden
death in children and young adults.[5,6,7,8,9] Our previously
published data on VLCAD-deficient mice showed that when the
fasting and cold stresses were introduced, these animals exhibited
decreased survival, recapitulating the clinical phenotypes of
children with VLCAD deficiency.[10] In a previous study[1], we
documented that, at birth, the surviving mice showed marked
upregulation of both the peroxisome proliferator-activated recep-
torc (PPARc) coactivator-1 alpha (PGC-1a), which is a critical
regulator of mitochondrial biogenesis, as well as acyl-CoA synthase,
which is a facilitator of sarcolemmal fatty acid uptake.[1] The
induction of these genes at birth further supported our hypothesis
that the induction of these fat metabolism genes in the heart at birth
is part of a feedback-regulated circuit that plays a critical role in
survival in VLCAD deficiency. Another protein, TMEM135,
which had not been previously characterized, was also found to be
elevated in VLCAD-deficient mice on the first day of life. In this
report, we sought to elucidate the role of TMEM135 in this
hypothesized survival circuit. TMEM135 was first identified in a
lung adenocarcinoma cell line cDNA library,[11] but a recently
published paper suggests that TMEM135 might be a critical gene
for adipogenesis and osteoblastogenesis.[12] Due to the fact that
TMEM135 was found to be phylogenetically highly conserved, we
hypothesized that the regulatory feedback circuit to which it
belongs, as well as its function, might be equally conserved.
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Caenorhabditis elegans (C. elegans), for studies of fat metabolism,
obesity and longevity.[13] Genes and pathways involved in
coordinating the transport, sorting and storage of lipids, as well
as fat metabolism, are well conserved in the worm and are critical
for its long-term survival. Therefore, we decided to investigate the
role of TMEM135 concurrently in the mouse and in the C. elegans
model.
In this study, we also set out to replicate in C. elegans the
metabolic model established in the mouse. We assessed the tissue
distribution and sub-cellular localization of TMEM135 in the
mouse and in the worm. We then used a C. elegans model to test the
role of TMEM135 in modulating fat stores, longevity and cold
sensitivity. This is the first study to demonstrate an association of
TMEM135 with mitochondrial fat metabolism, and the first
published data on a possible newly identified role for TMEM135
in enhancing fat storage, fat sorting and mitochondrial function in
mammalian organisms and in the nematode.
With a focus on potential target molecules linking TMEM135 to
a genetic network involved in fat biology and survival in the
mouse, we also sought to determine if there exists a link between
TMEM135 and insulin signaling within this genetic network. We
deemed it particularly relevant to examine this possibility because
it has been documented that insulin signaling plays a critical role in
regulating fat stores and enhancing longevity in C. ele-
gans.[14,15,16,17,18,19,20,21] Given the serious human out-
comes which result from VLCAD dehydrogenase enzyme
deficiency, namely cardiac pathologies and sudden death, our
studies may provide new insights into the molecular mechanisms
that place newborn infants with these defects at a greater risk for
sudden death.[22] There is a high degree of molecular
heterogeneity in disease outcome and prognosis.[5] However, it
remains to be determined whether molecular elements related to
this putative feedback regulatory circuit account for the clinical
spectrum in patients with identical genetic mutations. It is also
uncertain whether the changes we have identified in protein
expression patterns in the mice at birth[1] bear relevance to
human patients. Nevertheless, the results of our studies definitively
point to a critical role for TMEM135 in the biology of lipid storage
and lipid utilization in both the mouse and the worm.
Materials and Methods
VLCAD knockout mice
Ethics Statement. VLCAD-deficient mice were generated as
previously described.[1] Experiments involving these mice were
undertaken in accordance with the guidelines and regulations set
forth by the Animal Welfare Act, and the protocols were approved
by the Vanderbilt University Institutional Animal Care and Use
Committee (Approval ID numbers: M/00/535, M/03/070, and
M/03/116).
RNA extraction and northern blots
RNA extraction and northern blots were performed using
mouse heart tissue, as previously described.[1] RNA (10 mg per
sample lane) was resolved by electrophoresis in a formaldehyde-
agarose gel and then transferred to a nitrocellulose membrane. We
used 1 kb of the amino-terminal coding sequence of TMEM135 to
generate [a-
32P] dCTP-labeled Random-Primer probes, employ-
ing the Prime-It II kit (Stratagene, La Jolla, CA).
Protein isolation and immunoblotting
In the mouse, tissues were harvested representing the three
VLCAD genotypes (
+/+,
+/2, and
2/2) and were snap-frozen in
liquid nitrogen, as previously described.[10] Frozen tissue stored at
270uC was used to assess the tissue distribution of TMEM135 in
the heart, skeletal muscles, liver and brain of two-month-old mice.
Western blot analysis was performed as previously described.[10]
The expression of TMEM135 in the mouse was assessed with
peptide-specific rabbit polyclonal antibodies against TMEM135
(1:1000) (generated in immunized rabbits by Invitrogen antibody
services, Carlsbad, CA). In C. elegans, the expression levels of DAF-
16 (Santa Cruz Biotechnologies –sc 33738, 1:5000), SKN-1/
NRF2 (Abcam, ab 31163, 1:5000), SOD3 (sc 67088, 1:10000),
AKT (sc 8312, 1:1000), VLCAD (Strauss laboratory, rabbit
polyclonal antibody) as previously published,[1] PGC-1a (sc
13067, 1:1000), b- actin (sigma A 1978, 1:10000) and ACS (from
Dr. Jean Schaffer, Washington University, St. Louis, MO), as
previously published [1] were assessed using rabbit polyclonal
antibodies. Luminol-based detection was performed using horse-
radish peroxidase-conjugated anti-rabbit or anti-mouse IgG and
the chemilunescence reagent, ECL (Amersham Pharmacia
Biotech UK). Results are representative of at least three
independent experiments.
Sub-cellular fractionation
Sub-cellular fractionation of mouse hearts was performed as
previously described.
11 Hearts were harvested from euthanized
animals in conformity with humane animal codes. Hearts were
rinsed in phosphate-buffered saline (PBS), kept in ice-chilled PBS
and then transported to a cold room (4uC).[23] To minimize
protein degradation, initial experiments were performed at 4uC.
Mitochondrial fractions were obtained from pellets saved by
subsequent differential centrifugation. Sub-cellular organelles were
then re-suspended in 200 ml of re-suspension buffer and snap-
frozen in liquid nitrogen until use.
Protein multiple alignment
Multiple-alignment of TMEM135 orthologues was generated
with Clustal X 2.0.10 using default alignment parameters (Gonnet
Matrix series) loaded with the following protein sequences retrieved
from NCBI: NP_082619.3 for TMEM135 from Mus musculus,
NP_075069.3 for TMEM135 from Homo sapiens, NP_001013918.1
for TMEM135 from Rattus norvegicus, NP_001082887.1 for
TMEM135 from Danio rerio, NP_001085541.1 for TMEM135 from
Xenopus laevi, NP_649803.1, NP_731251.1, NP_731250.1 for
TMEM135-like protein from Drosophila melanogaster, and NP_
508800.2 for TMEM-135 from Caenorhabditis elegans.
K02G10.3/tmem-135 cloning
The full tmem-135 sequence from 850 bp upstream of the start
codon down to the last codon was amplified by PCR with the
TaKaRa LA Taq polymerase (Takara Bio Inc.) in an Eppendorf II
thermocycler (Eppendorf) using the following primers: forward
primer: 59- tataggatccgaacaggcaattatggaagacc-39, reverse primer:
59- tataggtaccgcatattcaacaagtggcatgtaaagc -39. It was then cloned
into pPD95.75 (Andrew Fire Laboratory, Addgene Kit, please see
http://www.addgene.org/docs/fire/andrew/datasheets.pdf) in
frame with the green fluorescent protein (GFP) between the
BamHI and KpnI restriction sites to generate the plasmid
pMA0002.
Handling of the worms and generation of C. elegans
transgenic strains
C. elegans strains were handled and maintained at 20uCa s
previously described.[24] The RB1443 strain carrying the 1.1 kb
deletion ok1646, which impairs the K02G10.3 expression product,
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N2 strainand the BC15594 strain[25] expressing the GFP under the
promoter of K02G10.3 (k02g10.3::GFP) were obtained from the
Caenorhabditis Genetic Centre (CGC, Minnesota). The original
RB1443 was outcrossed 4 times with N2 to remove undesirable
genetic alterations resulting from ethyl-methanesulfonate (EMS)
mutagenesisused togeneratethe originalstrain. Wehenceforth refer
to the K02G10.3 expression product as TMEM-135, which stands
for TMEM135-like protein. Homozygous mutant RB1443 animals
will be further designated as tmem-135(ok1646)o rtmem (2/2).
We also generated eight independent full-length K02G10.3::
GFP-expressing strains termed MAB123 (mjaEx086[K02G10.3::
GFP; rol-6(su1006)]) to MAB130 (mjaEx093[K02G10.3::GFP; rol-
6(su1006)]) by co-injection in young adult gonads pMA0002 at
25 ng/mL and pRF4 at 100 ng/mL. Single worm PCR was
performed according to the procedures set forth by Barstead et al.
(1991).[26] Fluorescent images for GFP were obtained by confocal
microscopy.
Life-span evaluation
For life-span evaluation, 20 worms from each group were
transferred to NGM/FUDR plates, placed at two different
temperatures (15 and 20uC) and scored every day. Delay of egg-
laying in C. elegans hermaphrodites lead to accumulation of mixed-
stage developing embryos in the uterus. These embryos eventually
hatch and kill their parent. To prevent this undesirable effectin our
lifespan assay, we used FUDR treatment of young adult worms to
render them sterile. [27] These studies were performed for three
independent cohorts, and the results are representative of triplicate
experiments.
Nile red staining and mitochondrial action potential
imaging
The vital dye, Nile Red (5 H-benzo [a] phenoxazine-5-one,
9diethylamino), was used to visualize fat droplets in live worms as
described in Greenspan et al.[28] Mitochondrial localization and
distribution were assessed using MitoTracker Red (M22425
Invitrogen, Carlsberg, CA) according to procedures outlined as
follows. Ten mM of MitoTracker Red in DMSO where diluted in
1 mL of M9 buffer (22 mM KH2PO4,2 2m MN a 2HPO4,8 5m M
NaCl, 1 mM MgSO4) in which synchronous L1 or young adult
worms were incubated for 2 hours in the dark. Worms were then
washed with M9 buffer in order to remove excess dye. Worms
were subsequently transferred to NGM/OP50 plates for 2 hours
to clear the intestinal tract of residual dye, after which they were
paralyzed with a mixture of 0.01% levamisole/0.1% tricaine and
mounted on 4% agarose pads for imaging. Fluorescence
observations were performed with an epifluorescence microscope
(Nikon Eclipse 80i, Nikon) equipped with a Lambda LS Xenon
lamp (Sutter Instrument Company) and Nikon Plan Fluor 20x dry
and Nikon Plan Apo 6061.3 oil objectives. The microscope was
coupled to a black-and-white camera (DS-Qi1Mc; Nikon)
operated by the Nikon Elements AR3.0 software (NES AR3.0).
Confocal images were acquired with a Zeiss LSM510 confocal
microscope (Carl Zeiss Microimaging Inc.) equipped with a Plan-
Apochromat 63x and a Plan-Neofluar 1006oil objectives with 1.4
and 1.3 apertures.
Cold exposure
L1 worms were mounted on agarose pads, covered with cover-
slips and left for 1 hour at either 4uCo ra t2 0 uC. Then, worms
were brought to room temperature for 30 minutes prior to
imaging. For each condition approximately 30 worms were
observed under an epifluorescence microscope, and 5 were
imaged by confocal microscopy.
Data analysis and statistics
Data were plotted as means 6 SEM. For GFP-fluorescence
integrated intensity, northern and western blot densitometry
analysis, two-tailed T-tests were used for single comparisons,
while one-way analysis of variance (ANOVA) was used for
multiple comparisons. Multiple comparisons were performed
using the SPSS software package (SPSS). Differences were deemed
significant for p,0.05. By convention, we noted *: p,0.05,
**: p,0.01, ***: p,0.001.
Results
TMEM135 is overexpressed in the heart of VLCAD-
deficient mice
We previously reported on a mouse model of VLCAD
deficiency[1,10,23] that exhibited lipid accumulation in the heart
as well as the marked induction of several indictors of lipid
metabolism at birth, including PPARa, adipophilin and acyl-CoA
synthase prior to any microscopic evidence of lipid droplets in the
heart.[1] We performed cDNA microarrays of the VLCAD-
deficient hearts[2,3,4], comparing one-day-old VLCAD-deficient
hearts to wild-type controls. Detail results of the microarray studies
are unpublished. These studies provided us with a previously
uncharacterized expressed sequence tag (EST) that was markedly
induced in hearts of VLCAD-deficient mice at birth. Results
obtained from northern blot analysis showed that this novel EST
was upregulated 4.3 (60.14)-fold in hearts of VLCAD
2/2 mice
compared with those of VLCAD
+/+ control mice (p,0.001). This
EST was also upregulated 1.5-fold in the VLCAD
2/2 mice
compared with VLCAD
+/2 mice (Fig. 1A and 1B). A sequence
BLAST of this EST produced a full-length mouse sequence,
including the 59 and 39 untranslated regions, which were found in
the NCBI database. This EST corresponded to the uncharacter-
ized gene, tmem135. Computer-generated analysis in protein
databases revealed that this TMEM135 and its orthologues are
membrane proteins, exhibiting 5 to 7 transmembrane domains,
with multiple putative PKC phosphorylation and tyrosine kinase
sites. The vertebrate sequences contain an epitope with isochemi-
cal homology to the 21 aa endothelin epitope and a putative
nuclear hormone receptor motif ‘‘IRNLDDEL’’.
TMEM135 is induced in mice with mitochondrial fatty
acid b-oxidation enzyme defects
To further characterize this novel protein, rabbit polyclonal
antibodies were raised against the putative endothelin domain and
against the carboxy terminal. We discovered, by western blot
analysis, that the epitope was abundantly expressed in high
energy-requiring tissues, such as the heart and the skeletal muscles
of VLCAD +/2 and VLCAD 2/2 mice (Fig. 1C and 1D).
Subsequently, we tested the long-chain acyl-CoA dehydrogenase-
deficient (LCAD) mouse hearts, which exhibit another form of
fatty acid b-oxidation enzyme deficiency. TMEM135 was also
found to be elevated in LCAD mutants (data not shown.) Both
models, the VLCAD and LCAD mice, demonstrate an inability to
metabolize very long- (C14–C18) and long- chain (C12–C14) fatty
acids. [29,30,31] These mice are also sensitive to the cold and
represent mouse models of human fatty acid b-oxidation defects.
Based on our experimental data, we posited that a link exists
between fatty acid metabolism and TMEM135 function in
mitochondrial fatty acid b-oxidation.
TMEM135 and Worm Fat Stores
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Our computer search of the NCBI database revealed that the
TMEM135 sequence is highly conserved across species from C.
elegans to humans, as shown by protein multiple alignments (Fig. 2).
The search further disclosed the existence of one short orthologue
in each vertebrate species (data not shown), 3 full-length
orthologues in Drosophila and a unique orthologue in C. elegans.
As this protein was heretofore unnamed, we are labeling the C.
elegans orthologue, TMEM-135 (TMEM135-like protein).
TMEM-135 is ubiquitous and expressed in dot-like
cytoplasmic organelles throughout development in C.
elegans
Given that this protein was highly conserved across species
(Fig. 2), we used C. elegans to further investigate its role in the
hypothesized metabolic feedback mechanism that regulates
survival under stress. We obtained a promoter::GFP-expressing
strain and cloned the full-length open reading frame in phase with
GFP to study the TMEM-135 expression pattern and sub-cellular
localization. In the tmem-135 promoter::GFP-expressing strain, as
well as in the eight independent TMEM-135::GFP-expressing
strains, we consistently observed an ubiquitous expression from the
pretzel embryo to the adult stage (Fig. 3A–C), despite mozaicism
due to the extra-chromosomal array. More specifically, tmem-135
expression was more strongly expressed in the lower intestine
(Fig. 3A and 3B) and in the pharynx (Fig. 3A and 3C). TMEM-
135::GFP showed a high level of expression throughout the entire
length of the intestine, as well as in all epithelia (Fig. 3D–F). The
sub-cellular localization of this protein appeared to correspond to
dot-like cytoplasmic structures of 0.2 to 1 micron in L1 worms.
TMEM135 expression shows an association with fat
droplets and mitochondria in mice and worms
We next determined the compartment to which the TMEM135
protein localizes. We first used sub-cellular fractionation to assess
the sub-cellular localization of TMEM135 in the mouse heart.
Our results revealed a strong enrichment of TMEM135 in the
mitochondrial and nuclear fractions (Fig. 4A and 4B). Immuno-
transmission-electron microscopy (ITEM) confirmed the mito-
chondrial localization and revealed an even stronger staining
around fat droplets and in mitochondria surrounding those in the
mouse heart (Fig. 4C). Some nuclear staining was observed (data
not shown), but with much less consistency, a result possibly due to
non-specific staining or because the putative nuclear localization
identified may be highly regulated (i.e., seen under specific
conditions). We next tested to determine whether, in C. elegans
expressing TMEM-135::GFP, stained organelles would corre-
spond to mitochondria or fat droplets. We used the lipophilic dyes,
Nile Red and Mitotracker Red, to assess the co-localization of
TMEM-135 with fat droplets or mitochondria, respectively. We
observed no co-localization of TMEM-135::GFP and Mito-
Tracker Red (mitochondrial) (Fig. 4D) in the worm, whereas
TMEM-135::GFP and Nile Red displayed very strong co-
localization (Fig. 4E). Together, the mouse and worm data
provide strong evidence that the TMEM135 protein is associated
with fat droplets, supporting our hypothesis that TMEM135 plays
a role in fat metabolism.
TMEM135 is upregulated upon fasting and cold exposure
in worms and in mice
Based on our findings that TMEM135 is highly expressed in
VLCAD mice at birth (when lipid stores are strongly mobilized),
and given a potential role for TMEM135 in fatty acid oxidation,
we hypothesized that TMEM135 protein levels would be
upregulated upon physiological stresses such as cold exposure
and fasting (conditions in which fat stores and fat utilization are
required). Thus, we introduced these stressors as functional tests to
demonstrate the role of TMEM135 in fat metabolism. We found
that TMEM135::GFP was upregulated upon 1 hour of cold
exposure in L1 worms (Fig 5A and 5B). We observed a 2 fold
increase in the average integrated-fluorescence signal upon cold
exposure in the worm (arbitrary unit of 100614 in control animals
vs 21365.5 in cold-exposed worms, p,0.01). Moreover, although
TMEM135 expression was not highly expressed in normal mouse
heart tissue, TMEM135 was upregulated 3.25 (60.03)-fold upon
Figure 1. RNA and protein expression of TMEM135 in mouse tissues. (A) Northern blot analysis of TMEM135 transcripts in newborn hearts of
mice deficient in the very long chain ACAD gene. (B) B is representative of quantification by densitometry of Northern blot in A.( C) Protein
expression of TMEM135 in different mouse tissues. (D) Quantification by densitometry of western blots in C. N= 3 per group for wild-type control
mice labeled (+/+) for VLCAD +/+, heterozygous mice (+/2) for VLCAD+/2, and null mutant mice (2/2) for VLCAD2/2.
doi:10.1371/journal.pone.0014228.g001
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(p,0.02) (Fig. 5C and 5D). These results confirm that TMEM135
plays a conserved role in stress conditions that require fat
mobilization.
Loss of TMEM-135 leads to reduction of fat stores in the
worm
Next, we hypothesized that TMEM135 may be involved in the
modulation of fat stores in the worm. To test this hypothesis, we
obtained the C. elegans deletion mutant, tmem135(ok1646). Then,
using Nile Red staining, we compared fat stores in wild-type,
TMEM-135::GFP-overexpressing and tmem135(ok1646) mutant
worms and found that the tmem135(ok1646) mutants exhibited
significantly weaker Nile Red staining compared with the other
strains. We observed a 41.8% (62.8%) reduction in Nile Red
staining in tmem135(ok1646) animals compared with N2 controls
(p,0.0002) (Fig. 6A and 6B). When compared with wild-type
controls, TMEM-135::GFP-expressing worms did not show any
significant difference in Nile Red staining. Additionally, pharyn-
geal pumping did not differ among the three genotypes (data not
shown), suggesting that the reduction in fat stores in tme-
m135(ok1646) worms was not due to reduced feeding. Hence,
these results support a direct role for TMEM-135 in the regulation
of fat stores in the worm.
TMEM-135 deletion reduces worm longevity while
overexpression increases it at 15uC
Based on the assumption that fat stores are regulated by
TMEM135, we hypothesized that changes in TMEM135 levels in
worms may affect their longevity. To test this hypothesis, we
measured differences in longevity among the three strains (wild-
type controls, tmem135 (ok1646) mutant and TMEM135::GFP-
overexpressing worms) at different temperatures. Longevity
experiments revealed that the tmem135 (ok1646) mutants lived for
a significantly shorter time than wild-type worms, both at 20uC
(normal growth conditions) and 15uC (low temperature), while
TMEM135::GFP-overexpressing worms lived for a significantly
longer time than wild-type worms at 15uC (Fig. 6C and 6D). The
experiments conducted at 15uC showed that, in growth conditions
requiring increased fat stores (low temperature), reduced
TMEM135 expression was associated with a shorter life-span,
while increased TMEM135 expression led to an increased life-
span. These results strongly suggest that TMEM135 plays a
pivotal role in the network that regulates the fat stores required for
survival under cold and normal conditions in the worm.
TMEM135 deletion is associated with reduced
mitochondrial potential in the worm
To better characterize survival differences in the cold, we used the
mitochondrial potential sensing ability of the Mitotracker Red
staining and compared fluorescence in the three C. elegans genotypes.
We found a 40.7% (68.0%) reduction in Red fluorescence in
tmem135(ok1646)animalscomparedwithwildtype-controls(p,0.02;
Fig. 6E). These results indicate that mitochondrial activity is
impaired in tmem135 (ok1646) worms, likely contributing to cold
sensitivity in the tmem135
2/2 animals. However, changes in
mitochondrial activity cannot explain increased longevity in the cold
for TMEM135::GFP mutants, as we did not observe a significant
difference in the amount of Mitotracker Red fluorescence between
TMEM-135::GFP-overexpressing animals and N2 controls.
Figure 2. Comparison of sequence homology analysis of TMEM135 in different species. TMEM135 is well conserved across species.
doi:10.1371/journal.pone.0014228.g002
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FoxO/DAF-16 is well known as an important requirement for
ensuring normal longevity in the worm.[15,16] Given the impact
of TMEM-135 deletion on the worm lifespan, we wondered if the
loss of TMEM-135 expression in tmem-135(ok1646) mutants would
be associated with a reduction of DAF-16 expression. Indeed,
western blot analysis showed a significant 60.7% (63.3%)
reduction in FoxO/DAF-16 expression in tmem-135(ok1646)
worms compared with wild-type controls (p,0.006) (Fig. 6F).
Furthermore, TMEM-135::GFP overexpression led to a 2.0-fold
up-regulation of FoxO/DAF-16 levels compared with wild-type
controls (p,0.002) (Fig. 6F). Based on these results, we have
concluded that TMEM135 is normally involved directly or
indirectly in FoxO/DAF-16/regulation. Additional studies are
needed to test whether DAF-16 down-regulation accounts for the
reduction in fat stores, mitochondrial membrane potential and life-
span in tmem135 (ok1646) worms.
TMEM135 deletion does not lead to protein expression
changes in the Nrf-2/SKN-1 antioxidant pathway
Longevity regulation in the worm implicates the conserved
Insulin/IGF-1 pathway which inhibits the two major longevity-
promoting transcription factors, FoxO/DAF-16 and Nrf2/SKN-1.
Since TMEM-135 expression was found to affect DAF-16
expression levels (Fig. 6F), we hypothesized that it could similarly
impact Nrf2/SKN-1 expression. To test this hypothesis, we
sought to determine whether tmem135(ok1646) mutant and
TMEM-135::GFP-overexpressing worms would exhibit an alter-
ation in Nrf2/SKN-1 levels. When compared with wild-type
worms, we found no differences (Fig. 7). We recognize, however,
that Nrf2/SKN-1 expression levels are not necessarily informative,
since Nrf2/SKN-1 activity regulation mainly relies on its
translocation to the nucleus where it exerts its effect. To gain
access to Nrf2/SKN-1 activity, we therefore quantified, by western
blot analysis, the protein levels of a classic downstream target of
Nrf2/SKN-1, superoxide dismutase, sod-3.[32] We found that the
antioxidant enzyme level was unchanged in the tmem135 (ok1646)
and TMEM135::GFP animals (Fig. 7). These results indicate that
TMEM135 does not interfere with the Nrf-2/SKN-1 antioxidant
pathway.
TMEM-135-dependent alteration in DAF-16 levels is
independent of AKT expression
FoxO/DAF-16 is a known downstream target of the Insulin/
IGF-1 pathway via inhibition by the AKT-1+AKT-2+SGK-1
complex. As DAF-16 levels were affected by TMEM-135, and
TMEM-135 was shown to regulate fat stores (Fig. 6A and 6B), an
implication of TMEM-135 in the Insulin/IGF-1 was deemed
likely. Therefore, we measured AKT levels by western blot
analysis in tmem-135(ok1646), TMEM-135::GFP-overexpressing
and wild-type worms. We found no significant differences in
AKT expression levels between the three genetic backgrounds
(Fig. 7), although we can’t rule out a possible involvement of AKT
or the classical Insulin/IGF-1 pathway in TMEM135-dependent
modulation of DAF-16 expression.
Figure 3. TMEM-135 distribution in C. elegans. Images in A, B and C were obtained using tmem-135 promoter-driven GFP to assess tmem-135
tissue expression. tmem-135 was found to be ubiquitously expressed at all stages (A, B, C; data not shown). Apparent differences in expression
pattern reflect the mosaic distribution of the transgene. (A) Shows tmem-135 expression pattern in the pretzel embryo. (B) Shows tmem-135
expression pattern in a L1 larva. (C) Shows tmem-135 expression pattern in an adult worm. Images in D, E and F were obtained using a GFP-tagged
full-length TMEM135 to observe TMEM135 sub-cellular localization. Panels D, E and F reveal that TMEM135 localizes to rounded sub-cellular
organelles of 0.2–0.5 microns in L1 larvae, which are particularly abundant in the intestine.
doi:10.1371/journal.pone.0014228.g003
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In this study, we utilized comparative biology between the
mouse and the nematode, C. elegans, to identify and characterize a
novel protein associated with mitochondrial fatty acid metabolism,
fat stores, longevity, and energy expenditure. We hypothesized
that this novel protein plays a critical role in a feedback regulatory
circuit involved in survival in VLCAD deficiency. Our results also
led us to undertake a systematic study linking TMEM135 to fat
storage and longevity in C. elegans. A novel finding of these pursuits
is that TMEM135 promotes longevity in the worm. The
TMEM135 transgene rescued the cold stress phenotype and
increased longevity under cold temperature conditions, while
TMEM135 deletion in the worm led to decreased longevity at all
experimental temperatures. These findings in both the worm and
in the mouse support our original hypothesis that TMEM135
plays a critical role for survival in response to cold stress, as well as
in the metabolic circuitry involving mitochondrial function and
energy expenditure. In humans, mitochondrial fatty acid oxidation
defects are associated with a variety of clinical phenotypes.[5,33]
We and others have hypothesized that there are co-founding
elements involved in the heterogeneity of clinical phenotypes and
Figure 4. TMEM135 localizes to fat droplets in the mouse and in C. elegans and to mitochondria close to fat droplets in the mouse.
Experiments in A, B and C were done in mouse tissue. (A) Western blot to assess protein expression of TMEM135 in sub-cellular fractions of the
mouse heart. TMEM135 specific antibody, 1:1000. Lane1: total protein, lane 2: nuclear fraction, lane 3: mitochondrial fraction, lane 4: microsomal
fraction, lane 5: a low speed sediment containing intercalated discs sediment and microsomes enriched in heart sarcoplasmic reticulum, lane 6:
cytosol. (B) Quantification by densitometry of western blot in A. C1, C2 and C3 are representative of Transmitted Immuno-Electron microscopy in
mouse heart tissue. (C1) Immunogold staining showing TMEM135 mostly in the mitochondria and along the Z-line in the sarcomere. M=
mitochondria, S= sarcomere. C2 and C3 show accumulation of the TMEM135 epitope in the surrounding of lipid droplets in mouse hearts. M=
mitochondria, Arrows= fat droplets, Arrowheads= TMEM135 gold stain. (D) Is representative of TMEM135::GFP staining with Mitotracker Red,
showing no co-localization of TMEM135 and the mitochondria in the worm. (E) Represents Nile red staining in the TMEM135 over-expressing animals.
This figure shows co-localization of the GFP and fat droplets in the worm, as indicated by the arrows. Experiments in this section were performed 3 or
4 times.
doi:10.1371/journal.pone.0014228.g004
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type correlation has been described.[36] Given that cold and
fasting stresses are often lethal for mice with defects in the fatty
acid b-oxidation pathway,[10,30] our results suggest a role for
TMEM135 among the plausible candidate genes involved in
modulating overall survival and/or stress-associated clinical
phenotypes. Future studies must address whether findings in the
worm will prove beneficial for elucidating the possible role of
TMEM135 in human patients with these metabolic gene defects.
Another novel finding in this report is the discovery that
TMEM135’s pro-longevity function seems linked to DAF-16
modulation, since we were able to show that TMEM135 deletion
or TMEM135 overexpression in vivo correlates with changes in
DAF-16 levels. Functional copies of DAF-16, an orthologue of the
mammalian FOX3a,[16,17] which, in both humans and worms,
determines longevity, also regulates fat storage in worms.[19] The
DAF-2 insulin receptor, IP3-kinase, AKT1 and AKT2, phosphor-
ylate Daf16/FOXO to inhibit its downstream targets. The
inhibition of DAF-2 signaling leads to the activation of DAF-16
through dephosphorylation, as well as the translocation of DAF-16
to the nucleus to activate transcription. The translocation of DAF-
16 between the cytosol and the nucleus through phosphorylation
and dephosphorylation is a dynamic process, serving as a true
switch for nutrient sensing, metabolic substrate utilization and
stress resistance. [37] There are several other pathways known to
regulate DAF-16. Among them, the targets of rapamycin (TOR)
kinase and c-Jun N-terminal kinase (JNK) have both been shown
to contribute to various cellular responses and to aging, possibly in
parallel or downstream of DAF-16.[38] JNK was recently found to
be a positive regulator of DAF-16. [39] It appears that TMEM135
modulates DAF-16 levels, fat stores and longevity in a pathway
either upstream or in parallel to the insulin-signaling pathway.
One hypothesis is that DAF-16 and TMEM135 act on an identical
pathway to modulate survival. This notion is strengthened by the
fact that the lifespan was shortened and DAF-16 and fat stores
were found to be reduced in the tmem-135-null worms. Ogg et al.
reported that fat accumulation assayed with Sudan Black is
reduced in daf-16(mgDF50) mutants. This group hypothesized that
DAF-16 acts as a repressor of metabolic genes that mediate energy
usage and that the loss of function of these proteins causes a
metabolic shift leading to a reduction in fat mobility. [17] A
metabolic shift to accumulate fat forms the basis for life-span
extension in the worm. In agreement with this theory, it has also
been shown that daf-2 and age-1 mutants (critical components of
the insulin signaling pathway) demonstrate increased longevity and
increased energy stores [21]. On the other hand, the fact that
TMEM135 seems to regulate both DAF-16 levels (a regulator of
lipid stores) and the lack of alteration in AKT and SOD levels
raises the possibility that TMEM135 and DAF-16 cooperate in
this metabolic shift through mechanisms which may be indepen-
dent of the insulin signaling pathway.
We recognize that there are limitations to our study. Our
analysis does not address how a loss of function in genes that affect
mitochondrial fatty acid metabolism leads to the activation of
TMEM135. Additionally, in the present study, we have not
addressed the mechanism(s) leading to DAF-16 dysregulation in
the absence of TMEM135. Our observation that the TMEM135
transgene increases DAF-16 levels but does not lead to an increase
in survival at 20uC, provides a basis for further studies. However,
our results corroborate previously published data showing that the
DAF-16 transgene does not lead to increased longevity, which is in
contrast to the increase seen with the reduction in DAF-2 function.
Future studies in the worm addressing targets of TMEM135 might
include the acyl-CoA synthase (ACS), the acyl-CoA dehydroge-
nases and PGC-1 a. Although levels of ACS, VLCAD and PGC-
1a were not changed in the TMEM135-deficient animals, we did
find that TMEM135::GFP-overexpressing mutants displayed
elevated levels of ACS, VLCAD and PGC-1a (Fig. 7). These
Figure 5. TMEM135 is elevated with the stresses of cold and fasting in the worm and in C57BL/6 mice. Figures A and B are
representative experiments in the worm. Fig. A shows the induction of TMEM135 with cold stress (4uC) in the worm, and Fig. B is the quantification of
average fluorescence levels exemplified in Fig. A. Values in these experiments are expressed as relative fluorescence intensity in mean 6 SEM. Figures
C and D were experiments done using C57BL/6 mice. The animals were subjected to overnight fasting and were exposed to the cold for 2 hours, as
previously published[10]. (C) Western blots of TMEM135 expression with fasting and cold stresses. (D) Quantification by densitometry of the western
blots shown in C, N=3 per group.
doi:10.1371/journal.pone.0014228.g005
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FoxO targets include these fatty acid-associated genes.[40] FoxO
transcription factors have been shown to enhance fatty acid uptake
and oxidation, leading to increased levels of genes of fatty acid
metabolism (i.e. ACS) in C2 C12 cells.[41] FoxO is also known to
decrease the expression of Acyl-CoA carboxylase, leading to
reduced levels of malonyl-CoA, which is an inhibitor of fatty acid
oxidation.[41] In addition, PGC-1a has been shown to be a
master regulator of mitochondrial biogenesis,[42] as well as the
transcription co-factor providing homeostatic control of cellular
ATP. [43] Given that the overexpression of TMEM135 in the
GFP::TMEM135 worm led to increase survival in the cold, and
overexpression of ACS, VLCAD and PGC-1a, it is certainly
conceivable that TMEM135 is involved in facilitated fatty acid
flux, mitochondrial biogenesis, and energy expenditures. Our
findings place TMEM135 among the plausible candidate genes
involved in our hypothesized feedback regulatory circuit, a
circuit critical to enhancing the rate of survival in fatty acid
oxidation-deficient mice. Among the three C. elegans strains tested,
we did not detect changes in SOD3, NRF2 or AKT (Fig. 7). Thus,
we determined that TMEM135 regulates fat stores and longevity
in the worm by modulating DAF-16 levels and fat metabolism
genes, without causing apparent changes in oxidative stress
response genes.
In summary, we have demonstrated that TMEM135 is a key
regulator of longevity and fat stores in C. elegans. Both in the mouse
and in the worm, TMEM135 seems to be critical for enabling
adaptation to energy challenges (i.e. cold and fasting stresses). Data
obtained from studies in both the mouse and the worm suggests
that TMEM135 might function as a nutrient sensor and a
metabolic regulator gene. We propose that, in the mouse,
TMEM135 is part of a feedback regulatory circuit involving the
induction of several fat metabolic genes at birth that may aid in
survival. Based on the results of our recent experiments which
have tested this hypothesis, it could be anticipated that
disturbances in levels of any of the genes involved in this feedback
Figure 6. Nile Red staining and MitoTracker Red staining, survival differences and DAF-16 levels among the three C. elegans strains.
Fig. 6A is representative staining with Nile Red in the worm. (B) Represents semi-quantitative assessment of Nile Red staining intensity, N=4 per
group. (C) Represents survival analysis among the three C. elegans strains at 20uC. (D) Represents survival analysis among the three C. elegans strains
at 15uC. Wild-type = controls shown in red, tmem 135(2/2) = tmem135-deleted animals shown in black, TMEM135::GFP= C. elegans animal
overexpressing TMEM135 shown in green. (E) Quantitative assessment of MitoTracker Red fluorescence. (F) Western blot analysis and quantification
of DAF-16 levels in the three C. elegans strains, N=6 per group, values are mean 6 SEM.
doi:10.1371/journal.pone.0014228.g006
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well as sensitivity to cold and fasting stresses, which would be
consistent with the clinical phenotypes currently observed in
human infants with disease-causing genetic mutations in the
mitochondrial fatty acid oxidation pathway. Extrapolating from
the results of our studies, we note that, in cases of fatty acid
oxidation deficiency, the fact that there are compensatory genes
expressed at birth, and before the appearance of disease in the
mouse, it is possible that these molecules might serve as
therapeutic targets for restoring the metabolic profile necessary
for adequate energy balance, appropriate fatty acid flux and
sufficient metabolic stress response. Given that mitochondrial
energy metabolism, fat sorting and storage are also critical for
other aspects of cell function, our findings suggest that TMEM135
may also be a critical factor in a variety of other chronic illnesses.
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